Featured #Business Headlines

$PSTI Signs Term Sheet for $30 Million Equity Investment Agreement with a Leading Institutional Life Sciences Fund

Innovative Medical is a publicly listed Chinese Company active in the healthcare industry, and is an affiliate of ZSVC, one of the largest technology-focused VC firms in China Funds to support late-stage...

Featured

$PSTI Advances Towards U.S. Clinical Trial in PLX-R18 & Announces Principal Investigator

Pluristem Advances Towards U.S. Clinical Trial in PLX-R18 and Announces Principal Investigator Dr. Hillard Lazarus of Case Western Reserve University will be the Principal Investigator of the trial The...

Featured

$PSTI Phase III Critical Limb Ischemia Study Wins $8M Grant From Europe’s Horizon 2020

Pluristem’s Phase III Critical Limb Ischemia Study Wins $8 Million Grant from Europe’s Horizon 2020 Program The study will enroll about 250 patients in Europe and the U.S. The grant will...

Featured

$PSTI Receives Positive Feedback from FDA; Gears Up For Phase III Trials

Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia   -CLI is a severe unmet medical need whose treatment addresses a $12 billion...

Markets

$PSTI Participates in Radiation Injury Treatment Network Conference

Pluristem Participates in Radiation Injury Treatment Network Conference Co-sponsored by National Institutes of Health’s NIAID HAIFA, Israel, July 20, 2016 (GLOBE NEWSWIRE) -- Pluristem Therapeutics...

Featured #Stock Picks 2016

Our New Alert: Pluristem’s ($PSTI) Stroke of Genius – Fundamentally Changing the Way We Treat Disease

The phrase “Stroke of Genius” is unfortunately a hackneyed expression these days. The concept it conveys is a fundamental paradigm shift achieved through the recognition and exploitation of simplicity....